Life Biosciences has raised $80m in a Series D financing [...]

Scaling production of adeno-associated virus vectors remains a key barrier [...]

UMass Chan Medical School, Caring Cross and Trenchant BioSystems have [...]

Complement Therapeutics doses first patient in Phase 1/Phase 2 Opti-GAIN [...]

PulseSight Therapeutics has completed dosing in its Phase 1 clinical [...]

AAVantgarde Bio has completed enrollment in LUCE-1, a first-in-human Phase [...]

Genethon and Hansa Biopharma report GNT-018-IDES trial data showing imlifidase [...]

Circio Holding has presented new in vivo data showing its [...]

Complement Therapeutics GmbH (CTx) has received clearance from the FDA [...]

Chiesi Group has entered into an exclusive global partnership with [...]